KIRLOSELEC

Envair Electrodyne Share Price

 

 

Start SIP in KIRLOSELEC

Start SIP

Performance

  • Low
  • ₹64
  • High
  • ₹70
  • 52 Week Low
  • ₹60
  • 52 Week High
  • ₹130
  • Open Price₹64
  • Previous Close₹64
  • Volume429
  • 50 DMA₹71.07
  • 100 DMA₹75.31
  • 200 DMA₹85.80

Investment Returns

  • Over 1 Month -0.37%
  • Over 3 Month -8.56%
  • Over 6 Month -10.62%
  • Over 1 Year -39.66%

Smart Investing Starts Here Start SIP with Envair Electrodyne for Steady Growth!

Invest Now

Envair Electrodyne Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -50.8
  • PEG Ratio
  • 0.6
  • Market Cap Cr
  • 33
  • P/B Ratio
  • 3.8
  • Average True Range
  • 4.93
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.66
  • RSI
  • 52.01
  • MFI
  • 33.89

Envair Electrodyne Financials

Envair Electrodyne Technicals

EMA & SMA

Current Price
₹69.99
+ 5.99 (9.36%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹67.95
  • 50 Day
  • ₹71.07
  • 100 Day
  • ₹75.31
  • 200 Day
  • ₹85.80

Resistance and Support

68 Pivot Speed
  • R3 77.99
  • R2 74.00
  • R1 71.99
  • S1 65.99
  • S2 62.00
  • S3 59.99

Envair Electrodyne Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-13 Quarterly Results
2025-08-11 Quarterly Results
2025-05-26 Audited Results
2025-02-10 Quarterly Results

Envair Electrodyne F&O

Envair Electrodyne Shareholding Pattern

No data available.

Envair Electrodyne FAQs

Envair Electrodyne share price is ₹69 As on 12 February, 2026 | 01:26

The Market Cap of Envair Electrodyne is ₹32.5 Cr As on 12 February, 2026 | 01:26

The P/E ratio of Envair Electrodyne is -50.8 As on 12 February, 2026 | 01:26

The PB ratio of Envair Electrodyne is 3.8 As on 12 February, 2026 | 01:26

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23